Our Product
Amendis’s HDNX is a genomic-measurement diagnostic test that is based on genomic analysis, algorithmics and artificial intelligence (AI). It is performed on tissue obtained from the biopsy of oral cavity cancer patients.
A diagnostic test that predicts the development of head and neck cancer metastasis
HDNX test measures the expression level of determined genes that are related to the spread of cancer through the lymphatic system. The technology is based on the findings that various cancers, as well as specific cancer stages, exhibit a characteristic expression profile of specific sets of genes. Such a specific gene expression profile was shown to identify with high accuracy oral cavity squamous cell carcinomas (SCC) and to predict possible lymphatic metastasis. The test shows a significant improvement in the prediction of the development of oral tongue SCC stages compared to the present accepted industry standard.
This innovative diagnostic tool may predict the necessity for the surgical removal of neck tumors and lesions in patients where oral cavity tumors have been diagnosed, and will prevent up to 40% of the surgeries routinely performed in clinic today, even when there is no evidence of metastases.